Arrggghhhh…
HR-2651 from the 2015-2015 Congressional Session summary says (just the first paragraph).
[h=3]Shown Here:
Introduced in House (06/04/2015)[/h]
Eliminating Disparities in Diabetes Prevention, Access, and Care Act of 2015
This bill amends the Public Health Service Act to require the National Institutes of Health to: (1) expand, intensify, and support activities regarding prediabetes and diabetes, particularly type 2, in minority populations; (2) award grants for a mentoring program for health care professionals to be more involved in weight counseling, obesity research, and nutrition; (3) provide for the participation of minority health professionals in diabetes-focused research programs; and (4) award grants for programs to establish a pipeline from high school to professional school that will increase minority representation in diabetes-focused health fields.
I don’t know if bill numbers are “re-used” or not or just revised.
For the 2017-2018 Congressional Session there is no summary yet posted online (introduced just earlier this week).
[TABLE]
[TR]
Sponsor: [TD]Rep. Barr, Andy [R-KY-6] (Introduced 05/25/2017)[/TD]
[/TR]
[TR]
Committees: [TD]House - Energy and Commerce[/TD]
[/TR]
[TR]
Latest Action: [TD]05/25/2017 Referred to the House Committee on Energy and Commerce. (All Actions)[/TD]
[/TR]
[/TABLE]
HR-2651’s Title
[h=4]Official Title as Introduced:[/h] To improve the integrity and safety of horseracing by requiring a uniform anti-doping and medication control program to be developed and enforced by an independent Horseracing Anti-Doping and Medication Control Authority.
It appears to me that 2015-2016’s HR-2651 isn’t related at all to 2017-2018’s version.
It also appears that, not surprisingly, the BH article was not entirely correct… this bill calls for what appears to be a new entity… Horseracing Anti-Doping and Medication Control Authority and not the U.S. Anti-Doping Agency.